Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04284
Species: Homo sapiens
Position : chr15:67442496-67442696
Year: 2018
Title: The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: thyroid gland papillary carcinoma
PMID:  29300379
MONDO: MONDO:0005075
Tissue: thyroid gland
Tissue Ontology ID: UBERON:0002046
Cell Source: TPC-1
CVCL ID: CVCL_6298
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay; allele-specific regulatory-variant assay
High Throughput Method: Expression microarray; microarray
Low Throughput Method: SNP-centered dual-luciferase reporter assay for rs17293632; SMAD3 siRNA knockdown; RT-qPCR; downstream SMAD3-network ChIP-qPCR (not enhancer-site ChIP); Luciferase reporter assay; Reporter assay
About Target Gene
Target gene : SMAD3
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_04282 chr15:67441595-67443595 thyroid gland malignant cell thyroid gland papillary carcinoma
E_04283 chr15:67441595-67443595 thyroid gland malignant cell thyroid gland papillary carcinoma
E_04285 chr15:67442496-67442696 thyroid gland malignant cell thyroid gland papillary carcinoma
E_04322 chr15:67442496-67442696 thyroid gland thyroid follicular epithelial cell thyroid gland papillary carcinoma
E_04325 chr15:67442496-67442696 thyroid gland thyroid follicular epithelial cell thyroid gland papillary carcinoma
Expression of Target Genes for the Enhancer